317 related articles for article (PubMed ID: 19747950)
1. Histone deacetylase inhibitors repress macrophage migration inhibitory factor (MIF) expression by targeting MIF gene transcription through a local chromatin deacetylation.
Lugrin J; Ding XC; Le Roy D; Chanson AL; Sweep FC; Calandra T; Roger T
Biochim Biophys Acta; 2009 Nov; 1793(11):1749-58. PubMed ID: 19747950
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitors increase human arylamine N-acetyltransferase-1 expression in human tumor cells.
Paterson S; Sin KL; Tiang JM; Minchin RF; Butcher NJ
Drug Metab Dispos; 2011 Jan; 39(1):77-82. PubMed ID: 20870783
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitors modulate the transcriptional regulation of guanylyl cyclase/natriuretic peptide receptor-a gene: interactive roles of modified histones, histone acetyltransferase, p300, AND Sp1.
Kumar P; Tripathi S; Pandey KN
J Biol Chem; 2014 Mar; 289(10):6991-7002. PubMed ID: 24451378
[TBL] [Abstract][Full Text] [Related]
4. The histone deacetylase inhibitor trichostatin A mediates upregulation of 5-lipoxygenase promoter activity by recruitment of Sp1 to distinct GC-boxes.
Schnur N; Seuter S; Katryniok C; Rådmark O; Steinhilber D
Biochim Biophys Acta; 2007 Oct; 1771(10):1271-82. PubMed ID: 17894944
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibitors block nuclear factor-κB-dependent transcription by interfering with RNA polymerase II recruitment.
Furumai R; Ito A; Ogawa K; Maeda S; Saito A; Nishino N; Horinouchi S; Yoshida M
Cancer Sci; 2011 May; 102(5):1081-7. PubMed ID: 21299717
[TBL] [Abstract][Full Text] [Related]
6. Trichostatin A and structurally related histone deacetylase inhibitors induce 5-lipoxygenase promoter activity.
Klan N; Seuter S; Schnur N; Jung M; Steinhilber D
Biol Chem; 2003 May; 384(5):777-85. PubMed ID: 12817474
[TBL] [Abstract][Full Text] [Related]
7. Shear stress-mediated chromatin remodeling provides molecular basis for flow-dependent regulation of gene expression.
Illi B; Nanni S; Scopece A; Farsetti A; Biglioli P; Capogrossi MC; Gaetano C
Circ Res; 2003 Jul; 93(2):155-61. PubMed ID: 12805238
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
Yokota T; Matsuzaki Y; Miyazawa K; Zindy F; Roussel MF; Sakai T
Oncogene; 2004 Jul; 23(31):5340-9. PubMed ID: 15107822
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitor induction of P-glycoprotein transcription requires both histone deacetylase 1 dissociation and recruitment of CAAT/enhancer binding protein beta and pCAF to the promoter region.
Kim SN; Kim NH; Lee W; Seo DW; Kim YK
Mol Cancer Res; 2009 May; 7(5):735-44. PubMed ID: 19435809
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of lymphangiogenic factor VEGF-C expression and production by the histone deacetylase inhibitor suberoylanilide hydroxamic acid in breast cancer cells.
Cheng HT; Hung WC
Oncol Rep; 2013 Mar; 29(3):1238-44. PubMed ID: 23242251
[TBL] [Abstract][Full Text] [Related]
11. Regulation of constitutive and microbial pathogen-induced human macrophage migration inhibitory factor (MIF) gene expression.
Roger T; Ding X; Chanson AL; Renner P; Calandra T
Eur J Immunol; 2007 Dec; 37(12):3509-21. PubMed ID: 18034423
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding.
Hu J; Colburn NH
Mol Cancer Res; 2005 Feb; 3(2):100-9. PubMed ID: 15755876
[TBL] [Abstract][Full Text] [Related]
13. Cell growth inhibition and gene expression induced by the histone deacetylase inhibitor, trichostatin A, on human hepatoma cells.
Chiba T; Yokosuka O; Fukai K; Kojima H; Tada M; Arai M; Imazeki F; Saisho H
Oncology; 2004; 66(6):481-91. PubMed ID: 15452378
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase A-dependent recruitment of RNA polymerase II, C/EBP beta and NF-Y to the rat GTP cyclohydrolase I proximal promoter occurs without alterations in histone acetylation.
Kapatos G; Vunnava P; Wu Y
J Neurochem; 2007 May; 101(4):1119-33. PubMed ID: 17394555
[TBL] [Abstract][Full Text] [Related]
15. Superior activity of a new histone deacetylase inhibitor (ZYJ-34c) in inhibiting growth of human leukemia cells by inducing p21WAF1 expression and cell cycle arrest.
Yang H; Xu W; Li Y; Lan P; Zhang J; Zhang Y; Zhang C
Anticancer Drugs; 2014 Aug; 25(7):767-77. PubMed ID: 24686006
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitors decrease Toll-like receptor-mediated activation of proinflammatory gene expression by impairing transcription factor recruitment.
Bode KA; Schroder K; Hume DA; Ravasi T; Heeg K; Sweet MJ; Dalpke AH
Immunology; 2007 Dec; 122(4):596-606. PubMed ID: 17635610
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibition is associated with transcriptional repression of the Hmga2 gene.
Ferguson M; Henry PA; Currie RA
Nucleic Acids Res; 2003 Jun; 31(12):3123-33. PubMed ID: 12799440
[TBL] [Abstract][Full Text] [Related]
18. Histone modifications on the adrenergic induction of type II deiodinase in rat pinealocytes.
Chik CL; Price DM; Ho AK
Mol Cell Endocrinol; 2011 Aug; 343(1-2):63-70. PubMed ID: 21704117
[TBL] [Abstract][Full Text] [Related]
19. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
Zhang Y; Fatima N; Dufau ML
Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
[TBL] [Abstract][Full Text] [Related]
20. Both Sp1 and Sp3 are responsible for p21waf1 promoter activity induced by histone deacetylase inhibitor in NIH3T3 cells.
Xiao H; Hasegawa T; Isobe K
J Cell Biochem; 1999 Jun; 73(3):291-302. PubMed ID: 10321829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
